Global Pre-Exposure Prophylaxis Market Growth 2022-2028
- LP 4911728
- 72 Pages
- March 2022
- Pharmaceuticals
The United States Pre-Exposure Prophylaxis market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pre-Exposure Prophylaxis market, reaching US$ million by the year 2028. As for the Europe Pre-Exposure Prophylaxis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pre-Exposure Prophylaxis players cover Gilead Sciences, Teva Pharmaceuticals, Strides Pharma Science, and Lupin, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pre-Exposure Prophylaxis market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Truvada
Discovy
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Adult
Adolescent
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Gilead Sciences
Teva Pharmaceuticals
Strides Pharma Science
Lupin
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pre-Exposure Prophylaxis Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pre-Exposure Prophylaxis by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pre-Exposure Prophylaxis by Country/Region, 2017, 2022 & 2028
2.2 Pre-Exposure Prophylaxis Segment by Type
2.2.1 Truvada
2.2.2 Discovy
2.3 Pre-Exposure Prophylaxis Sales by Type
2.3.1 Global Pre-Exposure Prophylaxis Sales Market Share by Type (2017-2022)
2.3.2 Global Pre-Exposure Prophylaxis Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pre-Exposure Prophylaxis Sale Price by Type (2017-2022)
2.4 Pre-Exposure Prophylaxis Segment by Application
2.4.1 Adult
2.4.2 Adolescent
2.5 Pre-Exposure Prophylaxis Sales by Application
2.5.1 Global Pre-Exposure Prophylaxis Sale Market Share by Application (2017-2022)
2.5.2 Global Pre-Exposure Prophylaxis Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pre-Exposure Prophylaxis Sale Price by Application (2017-2022)
3 Global Pre-Exposure Prophylaxis by Company
3.1 Global Pre-Exposure Prophylaxis Breakdown Data by Company
3.1.1 Global Pre-Exposure Prophylaxis Annual Sales by Company (2020-2022)
3.1.2 Global Pre-Exposure Prophylaxis Sales Market Share by Company (2020-2022)
3.2 Global Pre-Exposure Prophylaxis Annual Revenue by Company (2020-2022)
3.2.1 Global Pre-Exposure Prophylaxis Revenue by Company (2020-2022)
3.2.2 Global Pre-Exposure Prophylaxis Revenue Market Share by Company (2020-2022)
3.3 Global Pre-Exposure Prophylaxis Sale Price by Company
3.4 Key Manufacturers Pre-Exposure Prophylaxis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pre-Exposure Prophylaxis Product Location Distribution
3.4.2 Players Pre-Exposure Prophylaxis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pre-Exposure Prophylaxis by Geographic Region
4.1 World Historic Pre-Exposure Prophylaxis Market Size by Geographic Region (2017-2022)
4.1.1 Global Pre-Exposure Prophylaxis Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pre-Exposure Prophylaxis Annual Revenue by Geographic Region
4.2 World Historic Pre-Exposure Prophylaxis Market Size by Country/Region (2017-2022)
4.2.1 Global Pre-Exposure Prophylaxis Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pre-Exposure Prophylaxis Annual Revenue by Country/Region
4.3 Americas Pre-Exposure Prophylaxis Sales Growth
4.4 APAC Pre-Exposure Prophylaxis Sales Growth
4.5 Europe Pre-Exposure Prophylaxis Sales Growth
4.6 Middle East & Africa Pre-Exposure Prophylaxis Sales Growth
5 Americas
5.1 Americas Pre-Exposure Prophylaxis Sales by Country
5.1.1 Americas Pre-Exposure Prophylaxis Sales by Country (2017-2022)
5.1.2 Americas Pre-Exposure Prophylaxis Revenue by Country (2017-2022)
5.2 Americas Pre-Exposure Prophylaxis Sales by Type
5.3 Americas Pre-Exposure Prophylaxis Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pre-Exposure Prophylaxis Sales by Region
6.1.1 APAC Pre-Exposure Prophylaxis Sales by Region (2017-2022)
6.1.2 APAC Pre-Exposure Prophylaxis Revenue by Region (2017-2022)
6.2 APAC Pre-Exposure Prophylaxis Sales by Type
6.3 APAC Pre-Exposure Prophylaxis Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pre-Exposure Prophylaxis by Country
7.1.1 Europe Pre-Exposure Prophylaxis Sales by Country (2017-2022)
7.1.2 Europe Pre-Exposure Prophylaxis Revenue by Country (2017-2022)
7.2 Europe Pre-Exposure Prophylaxis Sales by Type
7.3 Europe Pre-Exposure Prophylaxis Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pre-Exposure Prophylaxis by Country
8.1.1 Middle East & Africa Pre-Exposure Prophylaxis Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pre-Exposure Prophylaxis Revenue by Country (2017-2022)
8.2 Middle East & Africa Pre-Exposure Prophylaxis Sales by Type
8.3 Middle East & Africa Pre-Exposure Prophylaxis Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pre-Exposure Prophylaxis
10.3 Manufacturing Process Analysis of Pre-Exposure Prophylaxis
10.4 Industry Chain Structure of Pre-Exposure Prophylaxis
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pre-Exposure Prophylaxis Distributors
11.3 Pre-Exposure Prophylaxis Customer
12 World Forecast Review for Pre-Exposure Prophylaxis by Geographic Region
12.1 Global Pre-Exposure Prophylaxis Market Size Forecast by Region
12.1.1 Global Pre-Exposure Prophylaxis Forecast by Region (2023-2028)
12.1.2 Global Pre-Exposure Prophylaxis Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pre-Exposure Prophylaxis Forecast by Type
12.7 Global Pre-Exposure Prophylaxis Forecast by Application
13 Key Players Analysis
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Information
13.1.2 Gilead Sciences Pre-Exposure Prophylaxis Product Offered
13.1.3 Gilead Sciences Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Gilead Sciences Main Business Overview
13.1.5 Gilead Sciences Latest Developments
13.2 Teva Pharmaceuticals
13.2.1 Teva Pharmaceuticals Company Information
13.2.2 Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Offered
13.2.3 Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Teva Pharmaceuticals Main Business Overview
13.2.5 Teva Pharmaceuticals Latest Developments
13.3 Strides Pharma Science
13.3.1 Strides Pharma Science Company Information
13.3.2 Strides Pharma Science Pre-Exposure Prophylaxis Product Offered
13.3.3 Strides Pharma Science Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Strides Pharma Science Main Business Overview
13.3.5 Strides Pharma Science Latest Developments
13.4 Lupin
13.4.1 Lupin Company Information
13.4.2 Lupin Pre-Exposure Prophylaxis Product Offered
13.4.3 Lupin Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lupin Main Business Overview
13.4.5 Lupin Latest Developments
14 Research Findings and Conclusion
Table 1. Pre-Exposure Prophylaxis Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pre-Exposure Prophylaxis Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Truvada
Table 4. Major Players of Discovy
Table 5. Global Pre-Exposure Prophylaxis Sales by Type (2017-2022) & (K Units)
Table 6. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2017-2022)
Table 7. Global Pre-Exposure Prophylaxis Revenue by Type (2017-2022) & ($ million)
Table 8. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2017-2022)
Table 9. Global Pre-Exposure Prophylaxis Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Pre-Exposure Prophylaxis Sales by Application (2017-2022) & (K Units)
Table 11. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2017-2022)
Table 12. Global Pre-Exposure Prophylaxis Revenue by Application (2017-2022)
Table 13. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2017-2022)
Table 14. Global Pre-Exposure Prophylaxis Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Pre-Exposure Prophylaxis Sales by Company (2020-2022) & (K Units)
Table 16. Global Pre-Exposure Prophylaxis Sales Market Share by Company (2020-2022)
Table 17. Global Pre-Exposure Prophylaxis Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Pre-Exposure Prophylaxis Revenue Market Share by Company (2020-2022)
Table 19. Global Pre-Exposure Prophylaxis Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Pre-Exposure Prophylaxis Producing Area Distribution and Sales Area
Table 21. Players Pre-Exposure Prophylaxis Products Offered
Table 22. Pre-Exposure Prophylaxis Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pre-Exposure Prophylaxis Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Pre-Exposure Prophylaxis Sales Market Share Geographic Region (2017-2022)
Table 27. Global Pre-Exposure Prophylaxis Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Pre-Exposure Prophylaxis Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Pre-Exposure Prophylaxis Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Pre-Exposure Prophylaxis Sales Market Share by Country/Region (2017-2022)
Table 31. Global Pre-Exposure Prophylaxis Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Pre-Exposure Prophylaxis Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Pre-Exposure Prophylaxis Sales by Country (2017-2022) & (K Units)
Table 34. Americas Pre-Exposure Prophylaxis Sales Market Share by Country (2017-2022)
Table 35. Americas Pre-Exposure Prophylaxis Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Pre-Exposure Prophylaxis Revenue Market Share by Country (2017-2022)
Table 37. Americas Pre-Exposure Prophylaxis Sales by Type (2017-2022) & (K Units)
Table 38. Americas Pre-Exposure Prophylaxis Sales Market Share by Type (2017-2022)
Table 39. Americas Pre-Exposure Prophylaxis Sales by Application (2017-2022) & (K Units)
Table 40. Americas Pre-Exposure Prophylaxis Sales Market Share by Application (2017-2022)
Table 41. APAC Pre-Exposure Prophylaxis Sales by Region (2017-2022) & (K Units)
Table 42. APAC Pre-Exposure Prophylaxis Sales Market Share by Region (2017-2022)
Table 43. APAC Pre-Exposure Prophylaxis Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Pre-Exposure Prophylaxis Revenue Market Share by Region (2017-2022)
Table 45. APAC Pre-Exposure Prophylaxis Sales by Type (2017-2022) & (K Units)
Table 46. APAC Pre-Exposure Prophylaxis Sales Market Share by Type (2017-2022)
Table 47. APAC Pre-Exposure Prophylaxis Sales by Application (2017-2022) & (K Units)
Table 48. APAC Pre-Exposure Prophylaxis Sales Market Share by Application (2017-2022)
Table 49. Europe Pre-Exposure Prophylaxis Sales by Country (2017-2022) & (K Units)
Table 50. Europe Pre-Exposure Prophylaxis Sales Market Share by Country (2017-2022)
Table 51. Europe Pre-Exposure Prophylaxis Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Pre-Exposure Prophylaxis Revenue Market Share by Country (2017-2022)
Table 53. Europe Pre-Exposure Prophylaxis Sales by Type (2017-2022) & (K Units)
Table 54. Europe Pre-Exposure Prophylaxis Sales Market Share by Type (2017-2022)
Table 55. Europe Pre-Exposure Prophylaxis Sales by Application (2017-2022) & (K Units)
Table 56. Europe Pre-Exposure Prophylaxis Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Pre-Exposure Prophylaxis Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Pre-Exposure Prophylaxis Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Pre-Exposure Prophylaxis Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Pre-Exposure Prophylaxis Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Pre-Exposure Prophylaxis Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Pre-Exposure Prophylaxis
Table 66. Key Market Challenges & Risks of Pre-Exposure Prophylaxis
Table 67. Key Industry Trends of Pre-Exposure Prophylaxis
Table 68. Pre-Exposure Prophylaxis Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Pre-Exposure Prophylaxis Distributors List
Table 71. Pre-Exposure Prophylaxis Customer List
Table 72. Global Pre-Exposure Prophylaxis Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Pre-Exposure Prophylaxis Sales Market Forecast by Region
Table 74. Global Pre-Exposure Prophylaxis Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Pre-Exposure Prophylaxis Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Pre-Exposure Prophylaxis Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Pre-Exposure Prophylaxis Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Pre-Exposure Prophylaxis Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Pre-Exposure Prophylaxis Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Pre-Exposure Prophylaxis Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Pre-Exposure Prophylaxis Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Pre-Exposure Prophylaxis Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Pre-Exposure Prophylaxis Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Pre-Exposure Prophylaxis Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Pre-Exposure Prophylaxis Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Pre-Exposure Prophylaxis Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Pre-Exposure Prophylaxis Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Pre-Exposure Prophylaxis Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Pre-Exposure Prophylaxis Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Pre-Exposure Prophylaxis Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Pre-Exposure Prophylaxis Revenue Market Share Forecast by Application (2023-2028)
Table 92. Gilead Sciences Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors
Table 93. Gilead Sciences Pre-Exposure Prophylaxis Product Offered
Table 94. Gilead Sciences Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Gilead Sciences Main Business
Table 96. Gilead Sciences Latest Developments
Table 97. Teva Pharmaceuticals Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors
Table 98. Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Offered
Table 99. Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Teva Pharmaceuticals Main Business
Table 101. Teva Pharmaceuticals Latest Developments
Table 102. Strides Pharma Science Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors
Table 103. Strides Pharma Science Pre-Exposure Prophylaxis Product Offered
Table 104. Strides Pharma Science Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Strides Pharma Science Main Business
Table 106. Strides Pharma Science Latest Developments
Table 107. Lupin Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors
Table 108. Lupin Pre-Exposure Prophylaxis Product Offered
Table 109. Lupin Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Lupin Main Business
Table 111. Lupin Latest Developments
List of Figures
Figure 1. Picture of Pre-Exposure Prophylaxis
Figure 2. Pre-Exposure Prophylaxis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pre-Exposure Prophylaxis Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pre-Exposure Prophylaxis Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pre-Exposure Prophylaxis Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Truvada
Figure 10. Product Picture of Discovy
Figure 11. Global Pre-Exposure Prophylaxis Sales Market Share by Type in 2021
Figure 12. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2017-2022)
Figure 13. Pre-Exposure Prophylaxis Consumed in Adult
Figure 14. Global Pre-Exposure Prophylaxis Market: Adult (2017-2022) & (K Units)
Figure 15. Pre-Exposure Prophylaxis Consumed in Adolescent
Figure 16. Global Pre-Exposure Prophylaxis Market: Adolescent (2017-2022) & (K Units)
Figure 17. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2017-2022)
Figure 18. Global Pre-Exposure Prophylaxis Revenue Market Share by Application in 2021
Figure 19. Pre-Exposure Prophylaxis Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Pre-Exposure Prophylaxis Revenue Market Share by Company in 2021
Figure 21. Global Pre-Exposure Prophylaxis Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Pre-Exposure Prophylaxis Revenue Market Share by Geographic Region in 2021
Figure 23. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2017-2022)
Figure 24. Global Pre-Exposure Prophylaxis Revenue Market Share by Country/Region in 2021
Figure 25. Americas Pre-Exposure Prophylaxis Sales 2017-2022 (K Units)
Figure 26. Americas Pre-Exposure Prophylaxis Revenue 2017-2022 ($ Millions)
Figure 27. APAC Pre-Exposure Prophylaxis Sales 2017-2022 (K Units)
Figure 28. APAC Pre-Exposure Prophylaxis Revenue 2017-2022 ($ Millions)
Figure 29. Europe Pre-Exposure Prophylaxis Sales 2017-2022 (K Units)
Figure 30. Europe Pre-Exposure Prophylaxis Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Pre-Exposure Prophylaxis Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Pre-Exposure Prophylaxis Revenue 2017-2022 ($ Millions)
Figure 33. Americas Pre-Exposure Prophylaxis Sales Market Share by Country in 2021
Figure 34. Americas Pre-Exposure Prophylaxis Revenue Market Share by Country in 2021
Figure 35. United States Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Pre-Exposure Prophylaxis Sales Market Share by Region in 2021
Figure 40. APAC Pre-Exposure Prophylaxis Revenue Market Share by Regions in 2021
Figure 41. China Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Pre-Exposure Prophylaxis Sales Market Share by Country in 2021
Figure 48. Europe Pre-Exposure Prophylaxis Revenue Market Share by Country in 2021
Figure 49. Germany Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Pre-Exposure Prophylaxis Revenue Market Share by Country in 2021
Figure 56. Egypt Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Pre-Exposure Prophylaxis Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Pre-Exposure Prophylaxis in 2021
Figure 62. Manufacturing Process Analysis of Pre-Exposure Prophylaxis
Figure 63. Industry Chain Structure of Pre-Exposure Prophylaxis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
